Marshall Wace, LLP Genmab A/S Transaction History

Marshall Wace, LLP

$78.4 Billion
Q4 2024

A detailed history of Marshall Wace, LLP transactions in Genmab A/S stock. As of the latest transaction made, Marshall Wace, LLP holds 1,122,296 shares of GMAB stock, worth $25.1 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,122,296

Previous 428,053 162.19%

Holding current value

$25.1 Million

Previous $10.4 Million 124.46%

% of portfolio

0.03%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$20.02 - $24.15 $13.9 Million - $16.8 Million	694,243 Added 162.19%	1,122,296 $23.4 Million
Q3 2024 Nov 14, 2024	SELL	$23.84 - $28.48 $5.25 Million - $6.27 Million	-220,326 Reduced 33.98%	428,053 $10.4 Million
Q2 2024 Aug 14, 2024	SELL	$25.13 - $30.27 $7.57 Million - $9.11 Million	-301,046 Reduced 31.71%	648,379 $16.3 Million
Q1 2024 May 15, 2024	BUY	$26.43 - $32.77 $19.4 Million - $24.1 Million	734,017 Added 340.76%	949,425 $28.4 Million
Q4 2023 Feb 14, 2024	BUY	$27.94 - $35.44 $128,775 - $163,342	4,609 Added 2.19%	215,408 $6.86 Million
Q3 2023 Nov 14, 2023	BUY	$35.27 - $42.24 $7.43 Million - $8.9 Million	210,799 New	210,799 $7.43 Million
Q4 2022 Feb 14, 2023	BUY	$33.8 - $47.06 $279,154 - $388,668	8,259 New	8,259 $350,000
Q2 2021 Aug 13, 2021	SELL	$32.88 - $44.57 $282,603 - $383,079	-8,595 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$30.92 - $44.4 $1.78 Million - $2.55 Million	-57,447 Reduced 86.99%	8,595 $282,000
Q4 2020 Feb 16, 2021	SELL	$33.66 - $40.76 $5.35 Million - $6.48 Million	-158,987 Reduced 70.65%	66,042 $2.69 Million
Q3 2020 Nov 16, 2020	SELL	$33.07 - $38.68 $9.63 Million - $11.3 Million	-291,274 Reduced 56.42%	225,029 $8.24 Million
Q2 2020 Aug 13, 2020	BUY	$20.05 - $33.89 $5.59 Million - $9.46 Million	279,003 Added 117.57%	516,303 $17.5 Million
Q1 2020 May 15, 2020	BUY	$17.15 - $25.22 $4.07 Million - $5.98 Million	237,300 New	237,300 $5.03 Million

Others Institutions Holding GMAB

# of Institutions

246

Shares Held

61.3M

Call Options Held

159K

Put Options Held

38K

View Full List

About GENMAB A/S

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $14.7B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

More about GMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account

Marshall Wace, LLP Genmab A/S Transaction History